Notice2022-02476
National Cancer Institute; Notice of Closed Meetings
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
February 7, 2022
Issuing agencies
Health and Human Services DepartmentNational Institutes of Health
Full Text
<html>
<head>
<title>Federal Register, Volume 87 Issue 25 (Monday, February 7, 2022)</title>
</head>
<body><pre>
[Federal Register Volume 87, Number 25 (Monday, February 7, 2022)]
[Notices]
[Page 6879]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2022-02476]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and/or contract proposals
and the discussions could disclose confidential trade secrets or
commercial property such as patentable material, and personal
information concerning individuals associated with the grant
applications and/or contract proposals, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Cancer Institute Special Emphasis
Panel; A Multilevel Approach to Connecting Underrepresented
Populations to Clinical Trials (CUSP2CT).
Date: March 9, 2022.
Time: 11:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute at Shady Grove, 9609 Medical
Center Drive, Room 7W140, Rockville, Maryland 20850 (Telephone
Conference Call).
Contact Person: David G. Ransom, Ph.D., Chief, Scientific Review
Officer, Special Review Branch, Division of Extramural Activities,
National Cancer Institute, NIH, 9609 Medical Center Drive, Room
7W140, Rockville, Maryland 20850, 240-276-6351,
<a href="/cdn-cgi/l/email-protection#a7c3c6d1cec389d5c6c9d4c8cae7c9cecf89c0c8d1"><span class="__cf_email__" data-cfemail="91f5f0e7f8f5bfe3f0ffe2fefcd1fff8f9bff6fee7">[email protected]</span></a>.
Name of Committee: National Cancer Institute Special Emphasis
Panel; The Role of Epstein Barr Virus (EBV) Infection in Non-Hodgkin
Lymphoma (NHL) and Hodgkin Disease (HD) Development with or without
an Underlying HIV Infection (U01).
Date: March 24, 2022.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute Shady Grove, 9609 Medical
Center Drive, Room 7W104, Rockville, Maryland 20850 (Telephone
Conference Call).
Contact Person: Robert F. Gahl, Ph.D., Scientific Review
Officer, Special Review Branch, Division of Extramural Activities,
National Cancer Institute, NIH, 9606 Medical Center Drive, Room
7W104, Rockville, Maryland 20850, 240-276-7869, <a href="/cdn-cgi/l/email-protection#80f2efe2e5f2f4aee7e1e8ecc0eee9e8aee7eff6"><span class="__cf_email__" data-cfemail="691b060b0c1b1d470e08010529070001470e061f">[email protected]</span></a>.
Name of Committee: National Cancer Institute Special Emphasis
Panel; R13 Conference Grant Review.
Date: March 24, 2022.
Time: 11:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute at Shady Grove, 9609 Medical
Center Drive, Room 7W552, Rockville, Maryland 20850 (Telephone
Conference Call).
Contact Person: Jeanette Irene Marketon, Ph.D., Scientific
Review Officer, Program Coordination and Referral Branch, Division
of Extramural Activities, National Cancer Institute, NIH, 9609
Medical Center Drive, Room 7W552, Rockville, Maryland 20850, 240-
276-6780, <a href="/cdn-cgi/l/email-protection#620807030c071616074c0f03100907160d0c220c0b0a4c050d14"><span class="__cf_email__" data-cfemail="97fdf2f6f9f2e3e3f2b9faf6e5fcf2e3f8f9d7f9feffb9f0f8e1">[email protected]</span></a>.
Name of Committee: National Cancer Institute Special Emphasis
Panel; TEP-11: SBIR Contract Review Meeting.
Date: March 31, 2022.
Time: 11:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Cancer Institute Shady Grove, 9609 Medical
Center Drive, Room 7W126, Rockville, Maryland 20850 (Telephone
Conference Call).
Contact Person: Susan Lynn Spence, Ph.D., Scientific Review
Officer, Research Technology and Contract Review Branch, Division of
Extramural Activities, National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W126, Rockville, Maryland 20850, 240-620-0819,
<a href="/cdn-cgi/l/email-protection#bfcccaccded191cccfdad1dcdaffd1d6d791d8d0c9"><span class="__cf_email__" data-cfemail="62111711030c4c1112070c0107220c0b0a4c050d14">[email protected]</span></a>.
Name of Committee: National Cancer Institute Special Emphasis
Panel; Cancer Center Support Grant.
Date: May 12, 2022.
Time: 2:00 p.m. to 3:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute at Shady Grove, 9609 Medical
Center Drive, Room 7W612, Rockville, Maryland 20850 (Telephone
Conference Call).
Contact Person: CAPT Shari Williams Campbell, DPM, MSHS,
Scientific Review Officer, Resources and Training Review Branch,
Division of Extramural Activities, National Cancer Institute, NIH,
9609 Medical Center Drive, Room 7W612, Rockville, Maryland 20850,
240-276-7381, <a href="/cdn-cgi/l/email-protection#b2c1dad3c0db9cd1d3dfc2d0d7dedef2dcdbda9cd5ddc4"><span class="__cf_email__" data-cfemail="35465d54475c1b5654584557505959755b5c5d1b525a43">[email protected]</span></a>.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer
Control, National Institutes of Health, HHS)
Dated: February 2, 2022.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-02476 Filed 2-4-22; 8:45 am]
BILLING CODE 4140-01-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on February 7, 2022.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.